Skip to main content

From the helm: Starpharma’s (ASX:SPL) Chief Executive Officer, Dr. Jackie Fairley

Grady Wulff
November 8, 2022
In this instalment of our From the helm series, Bell Direct’s Grady Wulff speaks to Starpharma’s (ASX:SPL) Chief Executive Officer, Dr. Jackie Fairley.
Starpharma Holdings Limited (ASX:SPL) is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers. In this video Dr. Fairley discusses:
  • (0:56) A brief overview of Starpharma
  • (2:31) Growing distribution network for Viraleze
  • (3:29) SPL’s exciting oncology portfolio and key partnerships with major companies
  • (4:56) How Viraleze works and the market opportunity going forward
  • (6:09) What’s coming up next for SPL

Note: This interview was filmed on 20 October 2022.

Morning Bell 21 May

Grady Wulff
May 21, 2025

Morning Bell 20 May

Bell Direct
May 20, 2025

Morning Bell 19 May

Grady Wulff
May 19, 2025

Weekly Wrap 16 May

Bell Direct
May 16, 2025

Morning Bell 15 May

Bell Direct
May 15, 2025

Morning Bell 14 May

Bell Direct
May 14, 2025

Morning Bell 13 May

Grady Wulff
May 13, 2025

Morning Bell 12 May

Bell Direct
May 12, 2025

Weekly Wrap 9 May

Bell Direct
May 9, 2025

Morning Bell 8 May

Sophia Mavridis
May 8, 2025

Morning Bell 7 May

Bell Direct
May 7, 2025